Literature DB >> 10431964

Management of increased intracranial pressure: a review for clinicians.

P Marik1, K Chen, J Varon, R Fromm, G L Sternbach.   

Abstract

Emergency physicians are frequently confronted with head-injured patients, many of whom have intracranial hypertension. Since direct correlations have been reported between increased intracranial pressure (ICP) and adverse outcome, it is important to rapidly identify and treat these patients. Furthermore, since the actual brain damage that occurs at the time of injury cannot be modified, the maximization of neurological recovery depends upon minimizing secondary insults to the brain, most notably preventing hypotension and hypoxemia. Volume resuscitation to maintain an adequate mean arterial pressure, airway control, and sedation and analgesia to prevent surges in ICP remain the cornerstone of early management. These principles and the emergency department management of the head-injured patient are reviewed in this paper.

Entities:  

Mesh:

Year:  1999        PMID: 10431964     DOI: 10.1016/s0736-4679(99)00055-4

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  4 in total

Review 1.  Therapy of intracranial hypertension in patients with fulminant hepatic failure.

Authors:  Murugan Raghavan; Paul E Marik
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

2.  Brain death and true patient care.

Authors:  Doyen Nguyen
Journal:  Linacre Q       Date:  2016-08

Review 3.  Advances in Intracranial Pressure Monitoring and Its Significance in Managing Traumatic Brain Injury.

Authors:  Usmah Kawoos; Richard M McCarron; Charles R Auker; Mikulas Chavko
Journal:  Int J Mol Sci       Date:  2015-12-04       Impact factor: 5.923

4.  Improved spatial memory, neurobehavioral outcomes, and neuroprotective effect after progesterone administration in ovariectomized rats with traumatic brain injury: Role of RU486 progesterone receptor antagonist.

Authors:  Ladan Amirkhosravi; Mohammad Khaksari; Vahid Sheibani; Nader Shahrokhi; Mohammad Navid Ebrahimi; Sedigheh Amiresmaili; Neda Salmani
Journal:  Iran J Basic Med Sci       Date:  2021-03       Impact factor: 2.699

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.